r 56865 has been researched along with aconitine in 1 studies
Studies (r 56865) | Trials (r 56865) | Recent Studies (post-2010) (r 56865) | Studies (aconitine) | Trials (aconitine) | Recent Studies (post-2010) (aconitine) |
---|---|---|---|---|---|
72 | 1 | 0 | 1,609 | 21 | 497 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Clerck, F; Lu, HR | 1 |
1 other study(ies) available for r 56865 and aconitine
Article | Year |
---|---|
R 56 865, a Na+/Ca(2+)-overload inhibitor, protects against aconitine-induced cardiac arrhythmias in vivo.
Topics: Aconitine; Animals; Anti-Arrhythmia Agents; Benzothiazoles; Calcium; Dose-Response Relationship, Drug; Hemodynamics; Lidocaine; Male; Piperidines; Random Allocation; Rats; Rats, Wistar; Sodium; Sodium Channels; Tetrodotoxin; Thiazoles; Verapamil | 1993 |